These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10685136)

  • 21. Role of nutritional supplementation in reducing the levels of homocysteine.
    Krishnaswamy K; Lakshmi AV
    J Assoc Physicians India; 2002 May; 50 Suppl():36-42. PubMed ID: 12186154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia and transplant coronary artery disease.
    Caldera A; Dec GW
    Transplantation; 2002 Nov; 74(10):1359-64. PubMed ID: 12451231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of MTHFR and RFC1 gene polymorphism with hyperhomocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population.
    Sukla KK; Raman R
    Eur J Clin Nutr; 2012 Jan; 66(1):111-8. PubMed ID: 21878957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of (early) folate status to primary and secondary coronary artery disease prevention.
    Muskiet FA
    Reprod Toxicol; 2005; 20(3):403-10. PubMed ID: 15964170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are B vitamins a risk factor for VTE? Perhaps.
    den Heijer M
    J Thromb Haemost; 2006 Feb; 4(2):309-11. PubMed ID: 16420556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are B vitamins a risk factor for venous thromboembolism? Yes.
    Eichinger S
    J Thromb Haemost; 2006 Feb; 4(2):307-8. PubMed ID: 16420555
    [No Abstract]   [Full Text] [Related]  

  • 28. Endpoints for homocysteine-lowering trials.
    Bostom AG; Garber C
    Lancet; 2000 Feb; 355(9203):511-2. PubMed ID: 10682995
    [No Abstract]   [Full Text] [Related]  

  • 29. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Homocysteine as a cardiovascular marker and risk factor].
    Pietrzik K
    Clin Res Cardiol; 2006; 95 Suppl 6():VI28-33. PubMed ID: 17013582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Myocardial Infarction in a Young Man with Hyperhomocysteinemia and Pulmonary Tuberculosis.
    Ren MY; Zhang CS; Zhang XJ; Zhong JQ
    Intern Med; 2016; 55(2):153-9. PubMed ID: 26781015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation.
    Guo H; Lee JD; Xing Y; Cheng J; Ueda T; Toyoda K; Geshi T
    Acta Cardiol; 2004 Oct; 59(5):503-6. PubMed ID: 15529554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
    Guo H; Lee JD; Ueda T; Cheng J; Shan J; Wang J
    Indian J Med Res; 2004 Jan; 119(1):33-7. PubMed ID: 14997992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine and coronary atherosclerosis.
    Mayer EL; Jacobsen DW; Robinson K
    J Am Coll Cardiol; 1996 Mar; 27(3):517-27. PubMed ID: 8606260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-vitamin status and concentrations of homocysteine in Austrian omnivores, vegetarians and vegans.
    Majchrzak D; Singer I; Männer M; Rust P; Genser D; Wagner KH; Elmadfa I
    Ann Nutr Metab; 2006; 50(6):485-91. PubMed ID: 16988496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent stroke in a young patient with celiac disease and hyperhomocysteinemia.
    Gefel D; Doncheva M; Ben-Valid E; el Wahab-Daraushe A; Lugassy G; Sela BA
    Isr Med Assoc J; 2002 Mar; 4(3):222-3. PubMed ID: 11908270
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.